Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Leukemia, Monocytic, Acute × Mitoxantrone × Clear all

Phase

Phase 2 8 Phase 3 7 Phase 1 7 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 2 Leukemia, Monocytic, Acute 1

Interventions

Gemtuzumab 2 Cytarabine 2 tipifarnib 1 fludarabine phosphate 1 Sorafenib 1 Mitoxantrone 1 Melphalan 1 Immunologic Techniques 1 Idarubicin 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Daunorubicin 1 DNA Methylation 1 Cytogenetic Analysis 1 Clofarabine 1 Cladribine 1 Busulfan 1 Azacitidine 1 Arsenic Trioxide 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05313958 2023-07-27

SCCLG-M5

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Monocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡